Propel Bio Management »

Kayne Anderson MLP Investment shares owned by Propel Bio Management

Quarter-by-quarter ownership of Kayne Anderson MLP Investment (KYN) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Kayne Anderson MLP Investment

Tip: Access up to 7 years of quarterly data

All positions including Kayne Anderson MLP Investment held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kayne Anderson MLP Investment by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.5M 147k 10.33
2024-03-31 $1.5M 147k 10.01
2023-12-31 $1.3M 147k 8.78

More positions owned by Propel Bio Management

Applied Therapeutics Comm (APLT)
Plains Gp Holdings Lp-cl Comm (PAGP)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Achieve Life Sciences Comm (ACHV)
Phathom Pharmaceuticals I Comm (PHAT)
Akero Therapeutics Comm (AKRO)
Avidity Biosciences Comm (RNA)
Ardelyx Comm (ARDX)
Abeona Therapeutics Comm (ABEO)
Fulcrum Therapeutics Comm (FULC)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Verrica Pharmaceuticals I Comm (VRCA)
Kura Oncology Comm (KURA)

View all positions for Propel Bio Management

Top funds holding Kayne Anderson MLP Investment

Morgan Stanley
Cetera Investment Advisers
Bank of America Corporation
Brown Advisory Holdings Incorporated
Royal Bank of Canada
Raymond James & Associates
Advisors Asset Management
Wells Fargo & Company
Kayne Anderson Capital Advisors, L.p
Stansberry Asset Management
Pathstone Holdings
Cadent Capital Advisors
Stifel Financial
Saba Capital Management
Zazove Associates

View all funds holding Kayne Anderson MLP Investment